The shelf life of NSE 9601 extended from 12 to 36 months!
Neuron-specific enolase (NSE) has been detected in patients with certain tumors, namely: neuroblastoma, small cell lung cancer, medullary thryroid cancer, carcinoid tumors, pancreatic endocrine tumors, and melanoma. Studies of NSE as a tumor marker have concentrated primarly on patients with neuroblastoma and small cell lung cancer. Measurement of NSE levels in patients with these two diseases can provide information about the extent of the disease and the patient's prognosis, as well as about the patient's response to treatment.
Product name | Product Code | Product Specification Sheet |
| 100115 | |
| 100116 |